glp-1 best price costs rise, but there are ways to save on weight-loss drugs Today marks a new era—@novonordisk

What is less often discussed is what those changes mean for your gut microbiome and your nutritional intake over time

Eli Lilly CEO David Ricks announces details of the Medicare GLP-1 bridge program, offering weight loss medications like Fondeo and Zepbound for $50 per month to 20 million eligible Medicare Part D patients starting July 1.

GLP-1 drugs such as Ozempic are accelerating interest in protein to address the loss of lean muscle mass that can accompany rapid weight loss.

Exploring the link between semaglutide and fertility

Starting GLP-1 weight loss treatment

This article examines clinical evidence for combination therapy, safety profiles, and how genetic predispositions in GLP-1 and glucose metabolism pathways may info